Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Peripheral T-cell lymphoma (PTL) is a heterogeneous group of non-Hodgkin lymphomas.
• Accurate immunophenotyping is crucial for diagnosing and classifying T-cell lymphomas.
• Understanding T-cell antigen expression is key to identifying novel therapeutic targets.

Purpose of the Study:

• To characterize the T-antigen expression profiles in patients with PTL.
• To investigate the relationship between immunophenotype and clinical presentation in PTL.
• To explore potential new therapeutic strategies for PTL based on its aggressive clinical course.

Main Methods:

• Utilized an extensive panel of T- and B-cell markers, including E-rosettes (Er) and monoclonal antibodies (anti-Leu 1-7), to analyze lymphoma cells.
• Histologic classification included diffuse large cell, mixed lymphoma, and small cell types.
• Assessed T-antigen expression to determine T-helper, T-suppressor, or universal T-antigen phenotypes.

Main Results:

• Identified 9 distinct T-cell immunophenotypes among 11 PTL cases, highlighting significant heterogeneity.
• Seven cases displayed novel T-phenotypes not aligning with normal T-cell development.
• PTL demonstrated aggressive clinical behavior, with frequent extranodal and cutaneous involvement, transient chemotherapy responses, and a median survival of nine months.

Conclusions:

• A comprehensive battery of monoclonal antibodies is essential for PTL detection due to variable T-antigen expression.
• Novel or idiosyncratic T-cell phenotypes may be a hallmark of PTL.
• The aggressive nature and poor response to current therapies underscore the urgent need for novel therapeutic strategies in PTL.